Literature DB >> 18703597

Tumor volume assessment by 18F-FDG PET/CT in patients with oral cavity cancer with dental artifacts on CT or MR images.

Chung-Hwan Baek1, Man Ki Chung, Young-Ik Son, Joon Young Choi, Hyung-Jin Kim, Yoo Jeong Yim, Young Hyeh Ko, Jeesun Choi, Jae Keun Cho, Han-Sin Jeong.   

Abstract

UNLABELLED: The purpose of this study was to investigate the clinical usefulness of PET/CT or CT-attenuated PET in the evaluation of patients with oral cavity cancer (OCC) in whom dental artifacts distorted the conventional CT or MR images of the oral cavity.
METHODS: A PET/CT scan, in addition to a CT or MRI scan, was performed in 69 patients with OCC who had dentures or dental implants. A total of 64 PET/CT, 64 CT, and 27 MR images were analyzed including images from scans performed on 40 patients with OCC without dental artifacts on the conventional images; these were used for comparison. The CT-attenuated PET scan for the detection of primary tumors was compared with the CT or MRI scan. We also evaluated the correlation between the PET/CT volume and the pathologic volume using a regression analysis. In addition, subgroup analysis was performed to determine what proportion of subjects benefited most from the PET/CT.
RESULTS: CT-attenuated PET detected more primary tumors than did CT in patients with OCC with dental artifacts (95.3% vs. 75.0%, respectively; P=0.0016). PET/CT volume with a standardized uptake value (SUV) cutoff point of 3.5 predicted the pathologic volume more accurately than did the other cutoff points in patients with OCC with or without artifacts. After comparing pathologic volume and PET/CT(SUV 3.5) volume, the following regression equation was developed: log (pathologic volume)=0.6 x log (PET/CT(SUV 3.5) volume) + 1.3 (R(2) = 0.42, P<0.0001). Subgroup analysis showed that the prediction of the pathologic volume from the PET/CT images was more reliable for tumors that were more than 2 cm in depth (R(2)=0.72).
CONCLUSION: For patients with OCC with dental artifacts on the conventional imaging, PET/CT could provide useful clinical information about the primary tumors, particularly in cases with advanced tumors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18703597     DOI: 10.2967/jnumed.108.051649

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  21 in total

1.  An exploratory pilot study into the association between microcirculatory parameters derived by MRI-based pharmacokinetic analysis and glucose utilization estimated by PET-CT imaging in head and neck cancer.

Authors:  Sotirios Bisdas; Oliver Seitz; Markus Middendorp; Nicole Chambron-Pinho; Theodosios Bisdas; Thomas J Vogl; Renate Hammerstingl; Ulrike Ernemann; Martin G Mack
Journal:  Eur Radiol       Date:  2010-05-05       Impact factor: 5.315

Review 2.  Functional imaging in radiation therapy planning for head and neck cancer.

Authors:  Luis A Pérez Romasanta; María José García Velloso; Antonio López Medina
Journal:  Rep Pract Oncol Radiother       Date:  2013-11-09

Review 3.  Role of fluorine-18 fluorodeoxyglucose PET/CT in head and neck oncology: the point of view of the radiation oncologist.

Authors:  Jon Cacicedo; Arturo Navarro; Olga Del Hoyo; Alfonso Gomez-Iturriaga; Filippo Alongi; Jose A Medina; Olgun Elicin; Andrea Skanjeti; Francesco Giammarile; Pedro Bilbao; Francisco Casquero; Berardino de Bari; Alan Dal Pra
Journal:  Br J Radiol       Date:  2016-08-02       Impact factor: 3.039

4.  18F-FDG PET/CT-based gross tumor volume definition for radiotherapy in head and neck cancer: a correlation study between suitable uptake value threshold and tumor parameters.

Authors:  Chia-Hung Kao; Te-Chun Hsieh; Chun-Yen Yu; Kuo-Yang Yen; Shih-Neng Yang; Yao-Ching Wang; Ji-An Liang; Chun-Ru Chien; Shang-Wen Chen
Journal:  Radiat Oncol       Date:  2010-09-02       Impact factor: 3.481

Review 5.  (18)F-FDG PET/CT quantification in head and neck squamous cell cancer: principles, technical issues and clinical applications.

Authors:  Gianpiero Manca; Eleonora Vanzi; Domenico Rubello; Francesco Giammarile; Gaia Grassetto; Ka Kit Wong; Alan C Perkins; Patrick M Colletti; Duccio Volterrani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-01-19       Impact factor: 9.236

Review 6.  Role of (18)F-FDG PET-CT in head and neck squamous cell carcinoma.

Authors:  P Castaldi; L Leccisotti; F Bussu; F Miccichè; V Rufini
Journal:  Acta Otorhinolaryngol Ital       Date:  2013-02       Impact factor: 2.124

7.  Voxel-wise correlation of functional imaging parameters in HNSCC patients receiving PET/MRI in an irradiation setup.

Authors:  Kerstin Zwirner; Daniela Thorwarth; René M Winter; Stefan Welz; Jakob Weiss; Nina F Schwenzer; Holger Schmidt; Christian la Fougère; Konstantin Nikolaou; Daniel Zips; Sergios Gatidis
Journal:  Strahlenther Onkol       Date:  2018-03-21       Impact factor: 3.621

8.  Positron emission tomography (PET) attenuation correction artefacts in PET/CT and PET/MRI.

Authors:  C Buchbender; V Hartung-Knemeyer; M Forsting; G Antoch; T A Heusner
Journal:  Br J Radiol       Date:  2013-05       Impact factor: 3.039

9.  Added value of a single-energy projection-based metal-artifact reduction algorithm for the computed tomography evaluation of oral cavity cancers.

Authors:  Kenichiro Hirata; Daisuke Utsunomiya; Seitaro Oda; Masafumi Kidoh; Yoshinori Funama; Hideaki Yuki; Morikatsu Yoshida; Yasuyuki Yamashita
Journal:  Jpn J Radiol       Date:  2015-08-19       Impact factor: 2.374

10.  Clinical Applications of FDG PET and PET/CT in Head and Neck Cancer.

Authors:  Akram Al-Ibraheem; Andreas Buck; Bernd Joachim Krause; Klemens Scheidhauer; Markus Schwaiger
Journal:  J Oncol       Date:  2009-08-20       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.